Drug Trial Radar · NCT06113445
A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V1)
Last checked: Nov 20, 2026Latest source record: Aug 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
467
Actual
Start
Nov 29, 2023
Primary completion
Feb 24, 2026
Study completion Feb 24, 2027
Sponsor
- Lead sponsor
- Incyte CorporationIncyte (INCY)
- Sponsor type
- Industry
- First posted
- Nov 2, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is being conducted to determine the efficacy and safety of povorcitinib in participants with nonsegmental vitiligo.
Conditions
- NonSegmental Vitiligo
Interventions
PovorcitinibDrug
Oral, Tablet
PlaceboDrug
Oral, Tablet
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of Participants Achieving a ≥ 75% Improvement From Baseline in the Facial Vitiligo Area Scoring Index (F-VASI75)Time frame: Week 52
Locations
100 sites in 10 countries. Site status is shown where the registry gives one.
Cahaba Dermatology
Hoover, Alabama
University of California Irvine
Irvine, California
Clinical Science Institute Clinical Research Specialists Inc
Santa Monica, California
Cura Clinical Research
Sherman Oaks, California
Sutter Health Palo Alto Medical Foundation Pamf Sunnyvale Center
Sunnyvale, California
Renaissance Research
Cape Coral, Florida
Encore Medical Research, Llc
Hollywood, Florida
Savin Medical Group, Rc
Miami, Florida
Skin Research of South Florida, Llc
Miami, Florida
San Marcus Research Clinic Inc.
Miami Lakes, Florida
Olympian Clinical Research
Tampa, Florida
Forcare Clinical Research
Tampa, Florida
Cleaver Medical Group
Cumming, Georgia
Dermatology and Surgery Specialists of North Atlanta
Marietta, Georgia
Pivotal Research Solutions
Stonecrest, Georgia
Options Research Group, Llc
Kokomo, Indiana
Allcutis Research, Llc
Beverly, Massachusetts
Metro Boston Clinical Partners
Brighton, Massachusetts
Great Lakes Research Group Inc
Bay City, Michigan
Wayne State University Physician Group Dermatology
Dearborn, Michigan
Revival Research Institute, Llc Dermatology
Troy, Michigan
Medisearch Clinical Trials
Saint Joseph, Missouri
Jdr Dermatology Research
Las Vegas, Nevada
Empire Dermatology
East Syracuse, New York
Sadick Dermatology Sadick Research Group
New York, New York
Derm Research Center of New York Inc
Stony Brook, New York
Dermatology Associates of Plymouth Meeting
Plymouth Meeting, Pennsylvania
International Clinical Research Tennessee Llc
Murfreesboro, Tennessee
University of Texas Physicians - Bellaire Station
Bellaire, Texas
Center For Clinical Studies
Houston, Texas
Progressive Clinical Research
San Antonio, Texas
Jordan Valley Dermatology Center
West Jordan, Utah
Clinical Research Partners Llc Crp Richmond Forest Avenue Office Building Location
Richmond, Virginia
Dermatology Specialists of Spokane
Spokane, Washington
Hopital Universitaire de Bruxelles/ Academisch Ziekenhuis Burssel
Brussel/ Brussels/bruxelles, Belgium
Universitair Ziekenhuis Gent (Uz Gent)
Ghent, Belgium
Centre Hospitalier Universitaire de Liege - Sart Tilman
Liège, Belgium
Cliniques Universitaires Ucl Saint-Luc
Woluwe-Saint-Lambert, Belgium
Dermatology Research Institute
Calgary, Alberta, Canada
Enverus Medical Research
Surrey, British Columbia, Canada
Showing 40 of 100 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.